
What We're Reading: Fauci in Modified Quarantine; Reasons for Halting Remdesivir Study; Unemployment Rate Projections
The nation’s top infectious disease expert, Anthony Fauci, MD, and other health officials are entering various levels of quarantine after potential exposure to coronavirus disease 2019 (COVID-19); the National Institute of Allergy and Infectious Diseases details how and why it halted a study on remdesivir in patients with COVID-19 early; the president’s economic advisers project rising unemployment rates.
Top Health Officials Undergo Quarantine After Potential Exposure
After potential exposure to a White House staffer who tested positive for coronavirus disease 2019 (COVID-19), the nation’s top infectious disease expert, Anthony Fauci, MD, said he will begin a “modified quarantine” as he was not in close proximity with the person infected, while other top health officials, such as FDA Commissioner Stephen Hahn, MD, and CDC Director Robert Redfield, MD, will undergo full quarantines. As reported by
Behind NIAID’s Decision to Halt Remdesivir Study
After halting its study 2 weeks ago examining the efficacy of Gilead Sciences’ antiviral drug remdesivir in patients with COVID-19, the National Institute of Allergy and Infectious Diseases (NIAID) discussed in a piece by
Economic Advisers Note Unemployment Rate May Surpass 20%
Yesterday, 2 of President Donald Trump’s top economic advisers, Kevin Hassett and Treasury Secretary Steven Mnuchin, projected that the unemployment rate will continue to rise nationwide amid the pandemic, with Hassett predicting that it may reach 20% by next month. According to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.